Position in NVCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$337,117
+$94,571 QoQ
Shares Held
22,252
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#123
of 214 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PDT Partners, LLC holds $14,686,519 across 10 Medical Devices names. NVCR ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
20,480 | $4,312,473 | |
| 2 | BRKR |
Bruker Corp
|
68,292 | $4,109,812 | |
| 3 | ATEC |
Alphatec Holdings, Inc.
|
387,592 | $3,352,670 | |
| 4 | CBLL |
Ceribell, Inc.
|
52,725 | $1,025,501 | |
| 5 | BVS |
Bioventus Inc.
|
42,113 | $397,546 | |
| 6 | CTKB |
Cytek Biosciences, Inc.
|
86,869 | $384,829 | |
| 7 | NVCR |
NovoCure Ltd
This page
|
22,252 | $337,117 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
17,844 | $269,265 |
All Filings in NVCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,117 | 22,252 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $242,546 | 22,252 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $287,718 | 22,252 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $383,732 | 21,558 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $2,390,913 | 80,232 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,751,857 | 112,083 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,227,668 | 188,422 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,943,472 | 188,322 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $369,845 | 24,772 | Shares | Sole | 2024-02-14 | |
| 2020-06-30 | $855,699 | 14,430 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||